Clinical trial

The Synergistic Effects of AIH and FES in Persons With MS

NCT06413602

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

OTHER · Unmapped registry intervention Acute Intermittent Hypoxia Find medicine records · Find other trials using this name

OTHER · Unmapped registry intervention Neuromuscular Electrical Stimulation Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

The Synergistic Effects of AIH and FES in Persons With MS

Design: INTERVENTIONAL · Status: ACTIVE NOT RECRUITING · Phase: NA

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2024-11-01

PhaseNA

Conditions

Multiple Sclerosisverified · MONDO: multiple sclerosis

Multiple Sclerosis, Relapsing-Remittingcandidate · MONDO: relapsing-remitting multiple sclerosis

Multiple Sclerosis, Secondary Progressivecandidate · MONDO: secondary progressive multiple sclerosis

Interventions

Acute Intermittent HypoxiaOTHER

Neuromuscular Electrical StimulationOTHER

Sponsors & collaborators

Shirley Ryan AbilityLablead sponsor

Northwestern Universitycollaborator

Mapped research locations

ChicagoIllinois, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06413602 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.